- Home
- / Avalon Pharma
Avalon Pharma
Revenue
﷼394 M
FY, 2024
Avalon Pharma Summary
Company Summary
- Overview
- Avalon Pharma (أڤالون فارما, also known as Middle East Pharmaceutical Industries) is a company that develops, manufactures, and markets pharmaceutical products. It offers health and generic prescription medicines in therapeutic areas of dermatological, respiratory, cardiovascular, genitourinary systems, musculoskeletal, anti-infectives, etc.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Riyadh, SA | view all locations
- Cybersecurity rating
Table of Contents
Key People
Hamoud Alanazi, Chief Administrative Officer
Mohamed Maher Al Ghannam, Managing Director, Chief Executive Officer & Board Member
Mohamed Metwally, Chief Commercial Officer
LocationsView all
4 locations detected
Riyadh, Riyadh Province HQ
Saudi Arabia
8146 King Muhammad V, Sulimaniyah
Dammam, Eastern Province
Saudi Arabia
Al-Nagm building, Dist. 6366, King Faisal Ibn Abd-Alaziz street, Al Mazruiyah 4902, 4th floor
Jeddah, Makkah Province
Saudi Arabia
Slama tower, Al Madinah Road, 5th Floor, Office 509
Dubai, Dubai
United Arab Emirates
Dubai Science Park Towers North Tower, Office 504
Avalon Pharma Financials
Summary Financials
- Revenue (Q3, 2025)
- ﷼108.0M
- Gross profit (Q3, 2025)
- ﷼66.2M
- Net income (Q3, 2025)
- ﷼8.3M
- Cash (Q3, 2025)
- ﷼19.4M
- EBIT (Q3, 2025)
- ﷼11.9M